Research progress of anticoagulants in atrial fibrillation

Most patients with atrial fibrillation (AF) will be treated with anticoagulants. In 2004, the American Heart Association updated the anticoagulant guidelines for AF and classified the target-specific oral anticoagulants as a new alternative. This review is to introduce the latest research progress of anticoagulants in AF.